Lupus, formally known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease in which the immune system attacks healthy tissue throughout the body. The Lupus Foundation of America estimates that around 1.5 million Americans live with some form of the disease, with women of color disproportionately affected — Black, Hispanic, Asian, and Native American women face a substantially higher risk than white women, per NIAMS. Lupus is famous for being unpredictable. Symptoms wax and wane, mimic dozens of other conditions, and can range from mild joint pain to life-threatening organ damage. This is a plain-language educational overview, not medical advice; lupus care should be led by a rheumatologist. This article is part of our guide to medical conditions.
The Many Faces of Lupus
SLE is one of several lupus subtypes. Discoid lupus (DLE) affects mostly the skin and produces disc-shaped scarring rashes. Subacute cutaneous lupus is another skin-predominant form. Drug-induced lupus is triggered by specific medications and usually resolves when the offending drug is stopped. Neonatal lupus affects babies born to mothers with certain antibodies. SLE, the systemic form, is what most people mean when they say “lupus.”
The disease’s hallmark is its variability. One patient may have years of mild fatigue and joint pain; another may present with kidney failure, seizures, or hemolytic anemia. A large share of SLE patients — roughly half in many series — eventually develop lupus nephritis, the most common organ-threatening complication.
Common Symptoms and the Butterfly Rash
Fatigue affects roughly 80 to 90 percent of patients and is often the most disabling symptom. Joint pain and swelling — usually small joints, symmetrically — affect the great majority. The classic malar (butterfly) rash across the cheeks and bridge of the nose appears in a substantial minority of patients, often after sun exposure. MedlinePlus describes this red rash, most often on the face, as a signature feature of the disease.
Other features include photosensitivity, mouth ulcers (often painless), hair loss, Raynaud’s phenomenon, fever, weight changes, and serositis (inflammation of the lining around the heart or lungs). Cognitive issues — what patients call “lupus fog” — affect a substantial minority. Because presentations are so diverse, lupus is sometimes called “the great imitator,” which is part of why diagnosis can take so long.
Diagnosis Takes Time
The 2019 EULAR/ACR classification criteria use a positive antinuclear antibody (ANA) at a titer of at least 1:80 as an entry point, plus additional weighted clinical and immunological criteria. Classification as SLE is supported when total weighted points reach a defined threshold across categories such as constitutional symptoms, hematologic abnormalities, neuropsychiatric features, mucocutaneous findings, serositis, joint involvement, renal disease, and specific autoantibodies. (These are classification criteria used largely for research consistency; an individual diagnosis is a clinical judgment made by your physician.)
The most specific autoantibodies for SLE are anti-double-stranded DNA (anti-dsDNA) and anti-Smith (anti-Sm). Complement levels (C3, C4) often drop during active disease. Importantly, ANA alone is not enough to diagnose lupus — a meaningful share of healthy people have a positive ANA with no disease. Time from symptom onset to diagnosis is often measured in years, which is why persistent, unexplained multisystem symptoms deserve evaluation.
Lupus Nephritis and Organ Involvement: The Major Concern
Kidney involvement affects a large proportion of SLE patients — commonly cited in the range of 40 to 60 percent — and drives much of the long-term morbidity. It often presents silently, with mild protein in the urine, microscopic blood, or a gradually rising creatinine, which is exactly why routine urinalysis and blood tests at every rheumatology visit are essential. Kidney biopsy classifies lupus nephritis into several classes; the more aggressive classes require immunosuppression directed by a specialist.
Treatment of severe lupus nephritis generally combines corticosteroids with an immunosuppressant such as mycophenolate mofetil or cyclophosphamide for induction, then a maintenance agent such as mycophenolate or azathioprine. Newer agents — voclosporin and belimumab — carry FDA approval for lupus nephritis and are increasingly added to standard regimens. All of these are prescriber-directed; this guide intentionally gives no dosing. With modern treatment, long-term kidney survival has improved substantially, though outcomes remain worse with delayed diagnosis and in some higher-risk groups.
Beyond the kidneys, lupus can affect the brain and nervous system, heart and its lining, lungs, and blood cells. Because some of these can escalate quickly, ongoing monitoring is not optional — and certain symptoms warrant urgent or emergency evaluation rather than waiting for the next scheduled visit.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden severe headache, seizure, new weakness or numbness, stroke-like symptoms, severe shortness of breath, chest pain, severe abdominal pain, very high fever, sudden vision changes, or signs of severe kidney problems (markedly reduced urine output, severe leg swelling). Lupus crises affecting the brain, heart, lungs, or kidneys can be life-threatening and need immediate evaluation.
Treatment Options
Hydroxychloroquine is the cornerstone of SLE management — recommended for nearly all patients regardless of disease severity because it reduces flares, helps protect organs over time, has favorable effects on cholesterol, and is associated with improved outcomes. It is prescriber-directed, and this guide does not provide doses.
For mild flares, NSAIDs and short courses of low-dose corticosteroids are common, used at the lowest effective amount and for the shortest reasonable time because long-term steroids carry their own risks. Moderate disease often requires steroid-sparing immunosuppressants such as methotrexate, azathioprine, or mycophenolate mofetil. More severe disease may need higher-dose corticosteroids, cyclophosphamide, or rituximab. Biologics specifically approved for lupus include belimumab (a B-cell modulator) and anifrolumab (a type I interferon receptor antagonist). Biologic annual costs can be very high before insurance, so verify current pricing and coverage. Every one of these medicines is chosen, dosed, and monitored by your specialist — no lupus medication should be started, stopped, or adjusted on your own.
Hydroxychloroquine and eye (retinal) screening
Because hydroxychloroquine is taken long term by so many patients, one specific safety point deserves its own heading: it carries a small but real long-term risk of retinal toxicity that can affect vision. For that reason, ophthalmology screening is standard — typically a baseline eye exam near the time of starting the drug and regular monitoring thereafter (more frequent after several years of use or with added risk factors), using tests such as automated visual fields and optical coherence tomography (per American Academy of Ophthalmology guidance). Keeping the daily amount within recommended weight-based limits lowers risk, and this too is managed by your prescriber. The practical takeaway: don’t skip your eye appointments, and report any change in vision promptly. Do not adjust your dose yourself.
Sun protection is non-negotiable. UV exposure triggers flares in many patients, including systemic flares — not just rashes. Daily broad-spectrum SPF 30+ sunscreen, sun-protective clothing, and avoiding peak-hour sun are basics. Smoking cessation is critical because smoking worsens lupus and can reduce hydroxychloroquine’s effectiveness.
Living With Lupus
Lupus is a chronic disease, not a death sentence. With modern treatment, the large majority of patients live many years after diagnosis, and many live a normal lifespan. Cardiovascular disease becomes a major late risk — accelerated atherosclerosis means SLE patients have a higher risk of heart attack than the general population, including younger women. Aggressive management of blood pressure, cholesterol, and diabetes matters.
Pregnancy planning deserves special attention. Women with lupus can have successful pregnancies, but ideally conception happens during periods of disease quiescence on pregnancy-compatible medications, planned in advance with the care team. Antiphospholipid antibodies, anti-Ro/La antibodies, and active nephritis all change risk and management. Coordination between rheumatology and high-risk obstetrics is standard, and some routine lupus drugs are continued in pregnancy while others must be changed — always under medical guidance.
Mental health matters. Depression and anxiety are common in SLE. Fatigue, chronic pain, body-image changes, and the unpredictability of flares all contribute. Our guide to medical conditions covers chronic disease management more broadly. Some readers benefit from comparing related autoimmune conditions in our Sjögren’s syndrome guide, since the two conditions overlap meaningfully.
Triggers and Flare Prevention
Common flare triggers include UV exposure, infection, surgical stress, certain medications (for example some sulfa drugs and antibiotics), pregnancy, and significant emotional stress. Many patients identify personal patterns — recognizing them helps anticipate and shorten flares. Consistent medication adherence, especially hydroxychloroquine, is one of the strongest levers for preventing flares.
Vaccination is generally safe and important. Influenza, COVID-19, pneumococcal, HPV, and shingles vaccines are commonly recommended; live vaccines are typically avoided in patients on strong immunosuppression, so timing should be coordinated with the care team. Sleep, regular gentle exercise, and stress management have measurable benefit.
When to See a Doctor
Persistent fatigue, joint pain, unexplained rashes, hair loss, mouth ulcers, fevers without obvious cause, or Raynaud’s phenomenon — especially in combination — warrant evaluation. Primary care physicians often initiate workup with ANA, complete blood count, urinalysis, and inflammatory markers; positive or concerning findings prompt rheumatology referral.
Patients with established lupus need rheumatology follow-up every 3 to 6 months when stable and more often during flares. Regular eye exams (for hydroxychloroquine), bone density testing in those on long-term steroids, kidney monitoring (urine and blood), and cardiovascular risk assessment are part of routine care.
Frequently Asked Questions
What is the life expectancy with lupus?
With modern treatment, the large majority of patients live many years after diagnosis, and many live a normal lifespan. Outcomes depend heavily on organ involvement, especially kidney disease, and on treatment adherence. Survival has improved substantially over the past several decades.
Is lupus hereditary?
Lupus has a genetic component but is not directly inherited in a single-gene pattern. First-degree relatives have a higher risk than the general population, but the absolute risk for any individual relative remains low. Environmental triggers interact with genetic predisposition to produce disease.
Can lupus go into remission?
Yes. With modern treatment, many patients achieve low disease activity or remission. Remission may or may not allow medication tapering — hydroxychloroquine is typically continued long term, and any tapering is decided by your rheumatologist, not on your own. Flares can occur years into remission, especially with triggers like infection or sun exposure.
Why do I need eye exams on hydroxychloroquine?
Hydroxychloroquine carries a small long-term risk of retinal toxicity that can affect vision, so ophthalmology screening (a baseline exam and regular monitoring thereafter) is standard. Screening aims to catch any early changes before they cause noticeable vision loss. Keep your appointments and report vision changes promptly; never adjust your dose yourself.
What foods should you avoid with lupus?
Specific dietary restrictions for lupus are limited, but alfalfa sprouts (which contain L-canavanine) have been linked to flares in some people and are often avoided. Otherwise, an anti-inflammatory eating pattern emphasizing vegetables, fruits, and fish, while limiting heavily processed foods, is widely recommended for general cardiovascular health.
TL;DR: Lupus (SLE) is a chronic, multisystem autoimmune disease with a variable course. Hydroxychloroquine is foundational for nearly all patients and requires regular eye (retinal) screening for toxicity. Lupus nephritis and other organ involvement are the biggest concerns — much of it is silent, so routine urine and blood monitoring is essential, and some crises are emergencies. Diagnosis uses a positive ANA plus weighted criteria; ANA alone isn’t enough. There’s no cure, but with a rheumatologist, sun protection, not smoking, vaccination, and pregnancy planning, most people live full lives. Every lupus medication is prescriber-directed.
Medical disclaimer: This article is educational information, not medical advice, and includes no medication dosing. Lupus is a serious disease that requires individualized care — do not start, stop, or change any medication on your own. Work with a rheumatologist, keep your monitoring appointments (including eye exams on hydroxychloroquine), and seek urgent care for the emergency symptoms described above.
The Bottom Line
Lupus is a serious chronic autoimmune disease, but it is also one where the trajectory has improved dramatically over the last few decades. Hydroxychloroquine for nearly everyone (with its eye-screening requirement), vigilant kidney and organ monitoring, aggressive cardiovascular risk reduction, and newer biologics for refractory disease have transformed outcomes. Sun protection, smoking cessation, vaccination, and pregnancy planning matter more than many patients realize. The path through lupus is rarely linear, but with informed rheumatology care and active self-management, most patients live full lives — including raising families, building careers, and reaching old age.
Sources
- Lupus Foundation of America — what is lupus, symptoms, and treatment resources (verify current pages)
- American College of Rheumatology — 2019 EULAR/ACR classification criteria and lupus/lupus nephritis treatment guidelines (verify current version)
- MedlinePlus (U.S. National Library of Medicine) — Lupus (SLE, butterfly rash, ANA testing, rheumatologist, no cure)
- NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) — Lupus health topic
- American Academy of Ophthalmology — recommendations on screening for hydroxychloroquine retinopathy (verify current guidance)